TSGΔ154-1054 is preferentially expressed in p53-mutated breast cancer specimens as shown in Table 1 (Chi-square test; p=0.0001) and Supplementary Figure S3A, which reveals that p53 is a critical factor that prohibits the occurrence of TSG101 aberrant splicing. This evidence concerns the gene TSG101 and breast carcinoma.